BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19444103)

  • 1. Novel agents in development for pediatric sarcomas.
    Hughes DP
    Curr Opin Oncol; 2009 Jul; 21(4):332-7. PubMed ID: 19444103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting insulin-like growth factor 1 receptor in sarcomas.
    Scotlandi K; Picci P
    Curr Opin Oncol; 2008 Jul; 20(4):419-27. PubMed ID: 18525338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel agents on the horizon for cancer therapy.
    Ma WW; Adjei AA
    CA Cancer J Clin; 2009; 59(2):111-37. PubMed ID: 19278961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel targeted therapies in the treatment of soft-tissue sarcomas.
    Chao J; Chow WA; Somlo G
    Expert Rev Anticancer Ther; 2010 Aug; 10(8):1303-11. PubMed ID: 20735315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting IGF-1R in the treatment of sarcomas: past, present and future.
    Kim SY; Wan X; Helman LJ
    Bull Cancer; 2009; 96(7):E52-60. PubMed ID: 19617179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New targets for therapy of sarcoma.
    Magenau JM; Schuetze SM
    Curr Opin Oncol; 2008 Jul; 20(4):400-6. PubMed ID: 18525335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of IGF-IR Inhibitors in Pediatric Sarcomas.
    Kolb EA; Gorlick R
    Curr Oncol Rep; 2009 Jul; 11(4):307-13. PubMed ID: 19508836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin-like growth factor system and sarcomas.
    Rikhof B; de Jong S; Suurmeijer AJ; Meijer C; van der Graaf WT
    J Pathol; 2009 Mar; 217(4):469-82. PubMed ID: 19148905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future.
    Ludwig JA
    Curr Opin Oncol; 2008 Jul; 20(4):412-8. PubMed ID: 18525337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel treatment strategies for soft tissue sarcoma.
    Kasper B; Gil T; D'Hondt V; Gebhart M; Awada A
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):9-15. PubMed ID: 17141519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Targeted therapy of sarcomas].
    Cassier PA; Dufresne A; El Sayadi H; Pissaloux D; Alberti L; Decouvelaere AV; Ranchere D; Ray-Coquard I; Blay JY
    Bull Cancer; 2008 Oct; 95(10):963-74. PubMed ID: 19004727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 1 clinical trials for sarcomas: the cutting edge.
    Subbiah V; Kurzrock R
    Curr Opin Oncol; 2011 Jul; 23(4):352-60. PubMed ID: 21519259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors in children with malignant gliomas.
    Herrington B; Kieran MW
    Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of chemotherapy in pediatric nonrhabdomyosarcoma soft-tissue sarcomas.
    Ferrari A
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):929-38. PubMed ID: 18533802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
    Wagner AD; Moehler M
    Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Other endpoints in screening studies for soft tissue sarcomas.
    Verweij J
    Oncologist; 2008; 13 Suppl 2():27-31. PubMed ID: 18434636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of high-dose therapy and autologous stem cell transplantation for pediatric bone and soft tissue sarcomas.
    Ek ET; Choong PF
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):225-37. PubMed ID: 16445375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy in adult soft tissue sarcoma.
    Jain A; Sajeevan KV; Babu KG; Lakshmaiah KC
    Indian J Cancer; 2009; 46(4):274-87. PubMed ID: 19749457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
    Crawford J
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target-based therapies in breast cancer: current status and future perspectives.
    Normanno N; Morabito A; De Luca A; Piccirillo MC; Gallo M; Maiello MR; Perrone F
    Endocr Relat Cancer; 2009 Sep; 16(3):675-702. PubMed ID: 19525314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.